Meta-analyses of the pooled data of 5 case-control studies [15–19] showed that the circulating irisin levels showed no significant differences between the NAFLD group and healthy group (Figure 2). Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.